Suven Pharma, Cohance Lifesciences announce merger

The overall transaction is expected to conclude over the next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *